BIOC logo

Biocept (BIOC) Cash From Investing

Annual CFI

-$807.00 K
+$765.00 K+48.66%

December 31, 2022

Summary

Performance

1-Year Change

+48.66%

3-Year Change

-9.75%

5-Year Change

+42.37%

15-Year Change

+42.37%

BIOC Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.19%
BIOC annual cash flow from investing activities is higher than 45.19% of companies in Healthcare sector

High & Low

All-time High

-$700.00

3-Year Low

-$1.57 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BIOC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BIOC next annual earnings announcement has not yet been scheduled

OtherBIOCcash flowmetrics:

Annual CFF

-$1.87 M
BIOC annual cash flow from financing activities is -$1.87 million

Annual CFO

-$13.29 M
BIOC annual cash flow from operations is -$13.29 million

Annual FCF

-$14.10 M
BIOC annual free cash flow is -$14.10 million

Annual CAPEX

$807.00 K
BIOC annual capital expenditures is $807.00 thousand

Quarterly CFI

-$22.00 K
+$69.00 K+75.82%

June 30, 2023

Summary

Performance

3-Month Change

+75.82%

1-Year Change

+89.86%

3-Year Change

-30.18%

5-Year Change

-19.57%

BIOC Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.04%
BIOC quarterly cash flow from investing activities is higher than 49.04% of companies in Healthcare sector

High & Low

All-time High

$0.00
BIOC quarterly cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$590.00 K

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

OtherBIOCcash flowmetrics:

Quarterly CFF

$2.97 M
BIOC quarterly cash flow from financing activities is $2.97 million

Quarterly CFO

-$3.09 M
BIOC quarterly cash flow from operations is -$3.09 million

Quarterly FCF

-$3.18 M
BIOC quarterly free cash flow is -$3.18 million

Quarterly CAPEX

$97.00 K
BIOC quarterly capital expenditures is $97.00 thousand

TTM CFI

-$605.00 K
+$195.00 K+24.38%

June 30, 2023

Summary

Performance

3-Month Change

+24.38%

1-Year Change

+42.65%

3-Year Change

+11.58%

5-Year Change

+17.72%

BIOC TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.5%
BIOC TTM cash flow from investing activities is higher than 47.5% of companies in Healthcare sector

High & Low

All-time High

$0.00
BIOC TTM cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$1.57 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

OtherBIOCcash flowmetrics:

TTM CFF

$1.91 M
BIOC TTM cash flow from financing activities is $1.91 million

TTM CFO

-$17.60 M
BIOC TTM cash flow from operations is -$17.60 million

TTM FCF

-$18.28 M
BIOC TTM free cash flow is -$18.28 million

TTM CAPEX

$680.00 K
BIOC TTM capital expenditures is $680.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BIOC Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+48.7%+89.9%+42.6%
3 y3 years-9.8%-30.2%+11.6%
5 y5 years+42.4%-19.6%+17.7%

BIOC Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+48.7%at high+96.3%at high+61.5%
5 y5-year-9.8%+48.7%-30.2%+97.3%-20.6%+66.1%
alltimeall time<-9999.0%+48.7%<-9999.0%+97.3%<-9999.0%+66.1%

Biocept Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2023
-
-$22.00 K(-75.8%)
-$605.00 K(-24.4%)
Mar 2023
-
-$91.00 K(-33.1%)
-$800.00 K(-0.9%)
Dec 2022
-$807.00 K(-48.7%)
-$136.00 K(-61.8%)
-$807.00 K(-36.0%)
Sep 2022
-
-$356.00 K(+64.1%)
-$1.26 M(+19.5%)
Jun 2022
-
-$217.00 K(+121.4%)
-$1.05 M(+10.1%)
Mar 2022
-
-$98.00 K(-83.4%)
-$958.00 K(-39.1%)
Dec 2021
-$1.57 M(+81.3%)
-$590.00 K(+293.3%)
-$1.57 M(-11.9%)
Sep 2021
-
-$150.00 K(+25.0%)
-$1.78 M(+7.3%)
Jun 2021
-
-$120.00 K(-83.1%)
-$1.66 M(+6.6%)
Mar 2021
-
-$712.00 K(-11.3%)
-$1.56 M(+80.0%)
Dec 2020
-$867.00 K(+17.9%)
-$802.70 K(+2677.5%)
-$867.00 K(+72.8%)
Sep 2020
-
-$28.90 K(+71.0%)
-$501.70 K(-26.7%)
Jun 2020
-
-$16.90 K(-8.6%)
-$684.20 K(-5.1%)
Mar 2020
-
-$18.50 K(-95.8%)
-$720.90 K(-2.0%)
Dec 2019
-$735.30 K(+406.1%)
-$437.40 K(+106.9%)
-$735.30 K(+146.8%)
Sep 2019
-
-$211.40 K(+294.4%)
-$297.90 K(+86.9%)
Jun 2019
-
-$53.60 K(+62.9%)
-$159.40 K(+28.3%)
Mar 2019
-
-$32.90 K(<-9900.0%)
-$124.20 K(-14.5%)
Dec 2018
-$145.30 K(-89.6%)
$0.00(-100.0%)
-$145.30 K(-70.3%)
Sep 2018
-
-$72.90 K(+296.2%)
-$489.90 K(-48.2%)
Jun 2018
-
-$18.40 K(-65.9%)
-$945.10 K(-28.8%)
Mar 2018
-
-$54.00 K(-84.3%)
-$1.33 M(-5.2%)
DateAnnualQuarterlyTTM
Dec 2017
-$1.40 M(+210.2%)
-$344.60 K(-34.7%)
-$1.40 M(+25.5%)
Sep 2017
-
-$528.10 K(+32.0%)
-$1.12 M(+70.4%)
Jun 2017
-
-$400.20 K(+214.6%)
-$654.90 K(+34.1%)
Mar 2017
-
-$127.20 K(+111.3%)
-$488.30 K(+8.2%)
Dec 2016
-$451.40 K(+173.2%)
-$60.20 K(-10.5%)
-$451.40 K(+3.2%)
Sep 2016
-
-$67.30 K(-71.2%)
-$437.50 K(+5.1%)
Jun 2016
-
-$233.60 K(+158.7%)
-$416.40 K(+80.7%)
Mar 2016
-
-$90.30 K(+95.0%)
-$230.40 K(+39.5%)
Dec 2015
-$165.20 K(-58.2%)
-$46.30 K(+0.2%)
-$165.20 K(-47.1%)
Sep 2015
-
-$46.20 K(-2.9%)
-$312.00 K(-32.4%)
Jun 2015
-
-$47.60 K(+89.6%)
-$461.30 K(+9.8%)
Mar 2015
-
-$25.10 K(-87.0%)
-$420.00 K(+6.4%)
Dec 2014
-$394.90 K(>+9900.0%)
-$193.10 K(-1.2%)
-$394.90 K(+95.7%)
Sep 2014
-
-$195.50 K(+3003.2%)
-$201.80 K(+3103.2%)
Jun 2014
-
-$6300.00(<-9900.0%)
-$6300.00(+800.0%)
Mar 2014
-
$0.00(0.0%)
-$700.00(0.0%)
Dec 2013
-$700.00(-91.3%)
$0.00(0.0%)
-$700.00(0.0%)
Sep 2013
-
$0.00(-100.0%)
-$700.00(0.0%)
Jun 2013
-
-$700.00(<-9900.0%)
-$700.00(<-9900.0%)
Mar 2013
-
$0.00
$0.00
Dec 2012
-$8000.00(-97.3%)
-
-
Dec 2011
-$295.40 K
-
-

FAQ

  • What is Biocept annual cash flow from investing activities?
  • What is the all time high annual CFI for Biocept?
  • What is Biocept annual CFI year-on-year change?
  • What is Biocept quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Biocept?
  • What is Biocept quarterly CFI year-on-year change?
  • What is Biocept TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Biocept?
  • What is Biocept TTM CFI year-on-year change?

What is Biocept annual cash flow from investing activities?

The current annual CFI of BIOC is -$807.00 K

What is the all time high annual CFI for Biocept?

Biocept all-time high annual cash flow from investing activities is -$700.00

What is Biocept annual CFI year-on-year change?

Over the past year, BIOC annual cash flow from investing activities has changed by +$765.00 K (+48.66%)

What is Biocept quarterly cash flow from investing activities?

The current quarterly CFI of BIOC is -$22.00 K

What is the all time high quarterly CFI for Biocept?

Biocept all-time high quarterly cash flow from investing activities is $0.00

What is Biocept quarterly CFI year-on-year change?

Over the past year, BIOC quarterly cash flow from investing activities has changed by +$195.00 K (+89.86%)

What is Biocept TTM cash flow from investing activities?

The current TTM CFI of BIOC is -$605.00 K

What is the all time high TTM CFI for Biocept?

Biocept all-time high TTM cash flow from investing activities is $0.00

What is Biocept TTM CFI year-on-year change?

Over the past year, BIOC TTM cash flow from investing activities has changed by +$450.00 K (+42.65%)